More NewsRead More
Five Prime Therapeutics Announces Option Exercise by GlaxoSmithKline for a Commercial License to a Novel Muscle Disease Target
September 15, 2014
Five Prime Therapeutics to Present at Morgan Stanley 2014 Global Healthcare Conference
September 03, 2014
Small companies lead the I-O class of Cancer Therapies
August 08, 2014
Nurix, Inc. Names Arthur T. Sands, M.D., Ph.D., Chief Executive Officer
September 18, 2014
Five Prime Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 5, 2014
July 29, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here